M/Z: 798.6237


Hit 2 annotations:  [4,10-bis(acetyloxy)-2,3-dihydroxy-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-2-yl]methyl hexadecanoate_[M-H2O+NH4]+; SM(d19:0/20:4(6E,8Z,11Z,14Z)+=O(5))_[M+NH4]+


在BioDeep NovoCell知识数据库中，参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值，但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性，这个参考离子不应用于注释。

Found 11 Reference Ions Near m/z 798.6237
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000052560 Unreliable 798.6237 798.6237 ~ 798.6237
MzDiff: none		 Not Annotated 1.65 (0%) Homo sapiens
[UBERON:0001052] rectum
MSI_000002439 Unreliable 798.6302 798.6302 ~ 798.6302
MzDiff: none		 Not Annotated 1.28 (0%) Rattus norvegicus
[UBERON:0001950] neocortex
MSI_000002530 Unreliable 798.6251 798.6251 ~ 798.6251
MzDiff: none		 [4,10-bis(acetyloxy)-2,3-dihydroxy-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-2-yl]methyl hexadecanoate (BioDeep_00002094946)
Formula: C49H82O8 (798.6009)		 0.63 (100%) Rattus norvegicus
[UBERON:0001950] neocortex
MSI_000003141 Unreliable 798.6302 798.6302 ~ 798.6302
MzDiff: none		 Not Annotated 1.82 (0%) Rattus norvegicus
[UBERON:0002037] cerebellum
MSI_000003247 Unreliable 798.6251 798.6251 ~ 798.6251
MzDiff: none		 [4,10-bis(acetyloxy)-2,3-dihydroxy-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-2-yl]methyl hexadecanoate (BioDeep_00002094946)
Formula: C49H82O8 (798.6009)		 0.45 (100%) Rattus norvegicus
[UBERON:0002037] cerebellum
MSI_000003723 Unreliable 798.6298 798.6298 ~ 798.6298
MzDiff: none		 PC(20:1(11Z)/P-18:1(11Z)) (BioDeep_00000029586)
Formula: C46H88NO7P (797.6298)		 1.74 (100%) Homo sapiens
[UBERON:0002107] liver
MSI_000004897 Unreliable 798.6251 798.6251 ~ 798.6251
MzDiff: none		 [4,10-bis(acetyloxy)-2,3-dihydroxy-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-2-yl]methyl hexadecanoate (BioDeep_00002094946)
Formula: C49H82O8 (798.6009)		 0.6 (100%) Rattus norvegicus
[UBERON:0002298] brainstem
MSI_000004987 Unavailable 798.6302 798.6302 ~ 798.6302
MzDiff: none		 Not Annotated -0.31 (0%) Rattus norvegicus
[UBERON:0002298] brainstem
MSI_000005896 Unavailable 798.6302 798.6302 ~ 798.6302
MzDiff: none		 Not Annotated -0.88 (0%) Rattus norvegicus
[UBERON:0002435] striatum
MSI_000006000 Unavailable 798.6251 798.6251 ~ 798.6251
MzDiff: none		 [4,10-bis(acetyloxy)-2,3-dihydroxy-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-2-yl]methyl hexadecanoate (BioDeep_00002094946)
Formula: C49H82O8 (798.6009)		 -1.24 (100%) Rattus norvegicus
[UBERON:0002435] striatum
MSI_000043988 Unreliable 798.6292 798.6292 ~ 798.6292
MzDiff: none		 3-Demethylubiquinone-9 (BioDeep_00000005142)
Formula: C53H80O4 (780.6056)		 2.09 (100%) Rattus norvegicus
[UBERON:0002264] olfactory bulb

Found 3 Sample Hits
Metabolite Species Sample
[4,10-bis(acetyloxy)-2,3-dihydroxy-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-2-yl]methyl hexadecanoate

Formula: C49H82O8 (798.6009)
Adducts: [M-H2O+NH4]+ (Ppm: 1.1) 		Rattus norvegicus (Brain)
Spectroswiss - sol_2x_br_2
Resolution: 17μm, 488x193

Description

SM(d19:0/20:4(6E,8Z,11Z,14Z)+=O(5))

Formula: C44H81N2O7P (780.5781)
Adducts: [M+NH4]+ (Ppm: 15.7) 		Homo sapiens (colorectal adenocarcinoma)
520TopL, 490TopR, 510BottomL, 500BottomR-profile
Resolution: 17μm, 147x131

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).
m/z_798.6237

Formula: - (n/a)
Adducts: (Ppm: 0) 		Homo sapiens (colorectal adenocarcinoma)
439TopL, 409TopR, 429BottomL, 419BottomR-profile
Resolution: 17μm, 157x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).